Coronavirus Vaccine

Coronavirus Vaccine

Explainer: How Worried Should We Be About Reports Of Blood Clots And Astrazeneca's Vaccine?
Coronavirus Outbreak Coronavirus Vaccine News

Explainer: How Worried Should We Be About Reports Of Blood Clots And Astrazeneca’s Vaccine?

According to experts, the vaccines developed by Pfizer and Moderna have been linked with increased risk of anaphylaxis, but they are still recommended because benefits outweigh the risks of the side effect, which can be treated ...
More
India Surpasses Single Day Record With Over 3 Million Vaccinations In One Day
Coronavirus Vaccine News

India Surpasses Single Day Record With Over 3 Million Vaccinations In One Day

According to the Union Health Ministry, more than 1 crore beneficiaries aged over 60 years have been covered in the vaccination drive in just 15 days ...
More
Over 35.9 Crore COVID-19 Vaccine Doses Administered Worldwide
Coronavirus Outbreak Coronavirus Vaccine News

Over 35.9 Crore COVID-19 Vaccine Doses Administered Worldwide

As of now, Denmark, Norway, Iceland, Bulgaria, Ireland, Netherlands, Germany, Italy, France, Spain, Portugal, Sweden and Luxembourg are the European countries that have suspended the AstraZeneca vaccine as a precautionary measure ...
More
National Vaccination Day 2021: Amid The COVID-19 Vaccination Drive, Several Ministers Urge Twitterati To Get Inoculated Against The Virus
Coronavirus Vaccine Swasth India

National Vaccination Day 2021: Amid The COVID-19 Vaccination Drive, Several Ministers Urge Twitterati To Get Inoculated Against The Virus

National Vaccination Day 2021 is significant as India has started its biggest vaccination drive, the COVID-19 immunisation programme, which has already crossed 3 crore mark ...
More
Explainer: Why Countries Are Halting The AstraZeneca Shot
Coronavirus Outbreak Coronavirus Vaccine News Swasth India

Explainer: Why Countries Are Halting The AstraZeneca Shot

Nearly a dozen countries including Germany, France and Italy temporarily suspended their use of AstraZeneca’s coronavirus vaccine after reports last week that some people in Denmark and Norway who got a dose developed blood clots, even though there’s no evidence that the shot was responsible ...
More
COVID-19 Vaccine Is Safe, Say Astrazeneca And UK Regulator
Coronavirus Outbreak Coronavirus Vaccine News

COVID-19 Vaccine Is Safe, Say Astrazeneca And UK Regulator

According to AstraZeneca, safety is of "paramount importance" and the company is continually monitoring the safety of its COVID-19 vaccine ...
More
WHO Grants Emergency Use Authorization To Johnson & Johnson Vaccine
Coronavirus Outbreak Coronavirus Vaccine News Swasth India

WHO Grants Emergency Use Authorization To Johnson & Johnson Vaccine

It is the third COVID-19 vaccine after the two-shot regimens of Pfizer/BioNTech and AstraZeneca to receive backing from the World Health Organisation ...
More
Pfizer-BioNTech’s COVID-19 Vaccine Can Protect Against Brazil Variant: Study
Coronavirus Outbreak Coronavirus Vaccine News

Pfizer-BioNTech’s COVID-19 Vaccine Can Protect Against Brazil Variant: Study

For the study, published by the New England Journal of Medicine on Monday (March 8), researchers at Pfizer, BioNTech and the University of Texas Medical Branch genetically engineered the virus to create versions carrying mutations found in a range of coronavirus variants, including P.1 ...
More
Indigenous COVID-19 Vaccine, Covaxin's Phase 2 Data Published In Lancet; Vaccine Safe, Induced High Neutralising Antibody
Coronavirus Outbreak Coronavirus Vaccine News

Indigenous COVID-19 Vaccine, Covaxin’s Phase 2 Data Published In Lancet; Vaccine Safe, Induced High Neutralising Antibody

In the phase 2 trial, the Bharat Biotech-ICMR’s COVID-19 vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the phase 1 trial ...
More
Interim Phase 3 Results Of COVID-19 Vaccine Covaxin ‘Encouraging’, More Data Needed: AIIMS Director
Coronavirus Outbreak Coronavirus Vaccine News

Interim Phase 3 Results Of COVID-19 Vaccine Covaxin ‘Encouraging’, More Data Needed: AIIMS Director

Covaxin is one of the two COVID-19 vaccines to have got emergency use license in India and is being used in India’s vaccination programme ...
More
COVID-19 Recovered People Showing Faster Antibody Response To Covishield Vaccine: Study
Coronavirus Vaccine News

COVID-19 Recovered People Showing Faster Antibody Response To Covishield Vaccine: Study

Covishield, a locally manufactured version by Pune’s Serum Institute of India and the indigenous Covaxin, from the Hyderabad-based company Bharat Biotech are the two COVID-19 vaccines approved for use in the country ...
More
Phase 3 Clinical Trials Of COVID-19 Vaccine, Covaxin Shows 81 Per Cent Efficacy, Says Bharat Biotech
Coronavirus Outbreak Coronavirus Vaccine News

Phase 3 Clinical Trials Of COVID-19 Vaccine, Covaxin Shows 81 Per Cent Efficacy, Says Bharat Biotech

The first interim analysis is based on 43 cases, of which 36 cases of COVID-19 were observed in the placebo group versus seven cases observed in the BBV152 (Covaxin) group, resulting in a point estimate of vaccine efficacy of 80.6 per cent, said Bharat Biotech ...
More